In addition, this study aim to investigate whether serum levels of interleukin 6, serum cathepsin B activity, or hyaluronic acid biomarkers reflect on intervertebral disc degeneration tissue status among patients with the intervertebral degenerative disease, control patients and patients with fractures. The gene discussed is IL6; the disease is neurodegenerative disease.